ASA in the News
By Valli Herman for Weedmaps News
The World Health Organization (WHO) has taken a historic step toward the international reform of regulations regarding cannabis with a letter to the United Nations advising that it broaden access to medical cannabis.
On Feb. 1, 2019, WHO published a letter in which it recommended that cannabis and cannabis resin no longer be considered controlled substances in international treaties. Specifically, WHO asked that cannabis and cannabis resin be removed from the highest restriction, Schedule IV of the Single Convention on Narcotic Drugs. The Schedule IV designation includes substances that are considered to have no therapeutic value. In the U.S., the Drug Enforcement Administration (DEA) classifies cannabis under Schedule I, a designation given to substances thought to have a high potential for abuse and no medical value. Cannabis is placed among LSD and heroin in that category.
By Steph Sherer for The Hill
John Flickner, a 78-year-old, wheelchair-bound senior, is a certified medical cannabis patient in New York, who consumes cannabis from a vaporizer to avoid having to use the types of opioids that kill more than 115 Americans every day. Earlier this month Flickner was evicted from his home in a federally subsidized building in Niagara Falls, NY and lost access to doctors and transportation due to his use of medical cannabis to treat post-injury back pain and muscle spasms that make it difficult for him to breathe.
By Thomas Mitchell for Westword
"Established in 2002 with over 100,000 active members in all fifty states, ASA is the largest national member-based organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research. It's time that Colorado had a chapter of ASA, and my intent with Safe Access Colorado is to strengthen and unite Colorado's patient and medical cannabis community!"
- Melanie Rodgers, ASA Colorado
By Carolyn Thompson for the Associated Press via Boston Globe
‘‘It’s really a clear evidence of discrimination, and medical marijuana should be treated like any other medication when it comes to living in subsidized housing,’’ -David Mangone
By Nicole Leonard for Press of Atlantic City
“Adult use laws do not create access for pediatric patients living with conditions such as epilepsy, cancer and other conditions,” - Debbie Churgai
Cannabis Industry Reacts as Utah Legislature Changes Voter Approved Prop 2 - Americans for Safe Access
By Danny Reed for mg
“The Utah Legislature seeks to create a completely unworkable system for the distribution of medical cannabis. Expect to see countless delays from Utah in implementing this program, and an incredibly reduced patient population compared to who would have qualified under Proposition 2. Even if this bill served as an improvement to what voters passed, which it unequivocally does not, it sends a clear message to the Utah electorate that their voice does not matter.” -David Mangone
By Manny Cruz for the Pacific Daily News
"Politicians very rarely will do anything simply because it's 'the right thing to do,'" Sherer said. "They represent communities, and if they aren't hearing from the community then nothing will happen. If you're looking at the future of medical cannabis on Guam and you're not part of it—it's not going to happen. Stay frustrated, and do something about it." - Steph Sherer
By Erin Durkin for NationalJournal
“I think for those who are opponents of this issue, there’s a strong federalism component that underlies it that makes it a lot, I think, easier to swallow. It basically says, ‘This is a state’s right to decide this policy and the federal government is going to take a hands-off approach.’” - David Mangone
By Isabelle Lichtenstein for Merry Jane
“We want people to talk to their doctors about it [medical cannabis]. We want them to be educated about how it works in their bodies. We want them to know about drug interactions if they’re dealing with issues. We want them to know how it can help them therapeutically.”- Debbie Churgai
By Danny Reed for mg
“Attorney General Sessions was one of the last remaining prohibitionists in Washington,” David Mangone, attorney, and Director of Government Affairs Americans for Safe Access, a national group that advocates for cannabis research and the rights of patients. With “Sessions’ departure, we are closer than ever to changing outdated and misinformed federal policy when it comes to cannabis, particularly when it comes to recognizing the medical uses of the plant for a number of debilitating conditions,” - David Mangone